XML 54 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK OPTIONS AND AWARDS (Details)
12 Months Ended
Dec. 30, 2017
USD ($)
Plan
$ / shares
shares
Dec. 31, 2016
$ / shares
shares
Jan. 02, 2016
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected term 3 years 6 months    
Volatility deviation 22.60%    
Risk free rate 1.47%    
Number of plans that have shares reserved for further issuance | Plan 1    
Minimum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Percentage of fair market value of stock on grant date for exercise price 100.00%    
Stock Appreciation Rights (SARs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense | $ $ 172,806    
Number of Units [Roll Forward]      
Outstanding at beginning of period (in shares) | shares 0 0  
Issued (in shares) | shares 149,500 0  
Forfeited (in shares) | shares (8,000) 0  
Outstanding at end of period (in shares) | shares 141,500 0 0
Weighted - Average Exercise Price [Roll Forward]      
Outstanding at beginning of period (in dollars per share) | $ / shares $ 0 $ 0  
Issued (in dollars per share) | $ / shares 20.39 0  
Forfeited (in dollars per share) | $ / shares 21.10 0  
Outstanding at end of period (in dollars per share) | $ / shares 20.36 $ 0 $ 0
SARs Grants Outstanding and Exercisable [Abstract]      
Minimum Range of Exercise Prices (in dollars per share) | $ / shares 19.10    
Maximum Range of Exercise Prices (in dollars per share) | $ / shares $ 21.10    
Outstanding (in shares) | shares 141,500    
Weighted- Average Remaining Contractual Life 4 years 2 months 12 days    
Weighted- Average Exercise Price (in dollars per share) | $ / shares $ 20.36    
Exercisable as of December 30, 2017 (in shares) | shares 0    
Exercisable, Weighted- Average Remaining Contractual life 0 years    
Exercisable, Weighted- Average Exercise Price (in dollars per share) | $ / shares $ 0    
Stock Options [Member]      
Number of Units [Roll Forward]      
Outstanding at beginning of period (in shares) | shares 0 0  
Issued (in shares) | shares 25,000 0 0
Forfeited (in shares) | shares 0 0  
Outstanding at end of period (in shares) | shares 25,000 0 0
Weighted - Average Exercise Price [Roll Forward]      
Outstanding at beginning of period (in dollars per share) | $ / shares $ 0 $ 0  
Issued (in dollars per share) | $ / shares 0 0  
Forfeited (in dollars per share) | $ / shares 0 0  
Outstanding at end of period (in dollars per share) | $ / shares 0 $ 0 $ 0
SARs Grants Outstanding and Exercisable [Abstract]      
Maximum Range of Exercise Prices (in dollars per share) | $ / shares $ 0    
Outstanding (in shares) | shares 25,000    
Weighted- Average Remaining Contractual Life 5 years    
Weighted- Average Exercise Price (in dollars per share) | $ / shares $ 0    
Exercisable as of December 30, 2017 (in shares) | shares 0    
Exercisable, Weighted- Average Remaining Contractual life 0 years    
Exercisable, Weighted- Average Exercise Price (in dollars per share) | $ / shares $ 0    
Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Restricted stock granted (in shares) | shares   0  
Stock Options and SARs [Member]      
Number of Units [Roll Forward]      
Issued (in shares) | shares 174,500    
SARs Grants Outstanding and Exercisable [Abstract]      
Outstanding options, intrinsic value | $ $ 1,484,375    
2010 Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares available for future grant (in shares) | shares 333,500